Clinical trials
Phase 2 Diabetes Mellitus trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
495 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 10 |
| 2002 | 9 |
| 2003 | 16 |
| 2004 | 9 |
| 2005 | 13 |
| 2006 | 26 |
| 2007 | 31 |
| 2008 | 40 |
| 2009 | 25 |
| 2010 | 33 |
| 2011 | 23 |
| 2012 | 26 |
| 2013 | 25 |
| 2014 | 23 |
| 2015 | 23 |
| 2016 | 15 |
| 2017 | 18 |
| 2018 | 17 |
| 2019 | 13 |
| 2020 | 15 |
| 2021 | 15 |
| 2022 | 12 |
| 2023 | 11 |
| 2024 | 8 |
| 2025 | 12 |
| 2026 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 338 |
| Terminated | 54 |
| Unknown status | 38 |
| Withdrawn | 20 |
| Recruiting | 20 |
| Not yet recruiting | 12 |
| Active, not recruiting | 8 |
| Suspended | 3 |
| Enrolling by invitation | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 26 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 20 |
| AstraZeneca | 13 |
| Takeda | 11 |
| GlaxoSmithKline | 9 |
| Eli Lilly and Company | 7 |
| Massachusetts General Hospital | 6 |
| Ain Shams University | 5 |
| Novartis Pharmaceuticals | 5 |
| Pfizer | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus | 495 |
| Diabetes Mellitus, Type 2 | 148 |
| Diabetes Mellitus, Type 1 | 62 |
| Insulin Resistance | 45 |
| Obesity | 41 |
| Glucose Metabolism Disorders | 29 |
| Diabetic Neuropathies | 24 |
| Diabetic Retinopathy | 22 |
| Hypertension | 22 |
| Metabolic Diseases | 21 |
Trials
Showing 51 to 75 of 495. Each trial links to its page on Pharma Observatory.
395 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.